France Proton Therapy Market to Exceed USD 1.5 Bn by 2021, States Renub Research in New Study Available at MarketPublishers.com
23 Feb 2017 • by Natalie Aster
LONDON – The French proton therapy marketplace is expected to surpass the USD 1.5 billion mark by 2021. The country’s proton therapy market is likely to nearly double in the offing from its actual market size as of 2016. So taking in consideration the needs of patients, France had technologically upgraded all two proton therapy centers to boost the capacity with a view to treating more patients.
Diversified scope of cutting-edge radiation treatment techniques and technologies exist, like image guided radiation therapy (IGRT), intensity modulated radiation therapy (IMRT), and stereotactic body radiation therapy (SBRT), among others. However, proton is known to be better, owing to the physical characteristics of protons, which stop at a given depth and supply the biggest portion of their energy the beams deliver equivalent or higher doses of radiation to the target whilst transporting fewer doses to neighbouring healthy tissues.
Insightful topical publication “France Proton Therapy Market, Forecast, Reimbursement Policies & Patients Treated at Centers” created by Verdict Retail presents an in-depth, all-round analysis of actual and untapped markets for proton therapy.
The research includes a detailed list of all currently operational and prospective proton therapy centers. It examines the economics of proton therapy comprising reimbursement policies. The study casts light on the 3 companies – IBA, Elekta and Varian Medical Systems, examining their proton therapy revenues from 2010 to 2021. A detailed analysis of the drivers and challenges is included. It gives comprehensive details about the number of proton therapy centers in the country. Moreover, the research outlines future possible prospects of the market development including forecasts through 2020.
More insightful research reports by Renub Research are available its page at MarketPublishers.com.